Background Analysis: US FDA Advisory Committee to Review Epidiolex by GW Pharmaceuticals for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome Report
Background Analysis: US FDA Advisory Committee to Review Epidiolex by GW Pharmaceuticals for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome Report